MDNA Stock News

Popular stocks:

Suncor Energy

Boeing

Mullen Automotive

NVIDIA

Norwegian Cruise Line

TOP Stocks:

Shares of other companies:

SEACOR Marine Holdings

Fidelity National Information Services

Medicenna Therapeutics (MDNA) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: September 12, 2023 (16:02)

Sector: Healthcare

The share price of Medicenna Therapeutics Corp. (MDNA) now

What analysts predict: $2.75

52-week High/Low: $0.839 / $0.151

50/200 Day Moving Average: $0.293 / $0.484

This figure corresponds to the Average Price over the previous 50/200 days. For Medicenna Therapeutics stocks, the 50-day moving average is the support level today.

For Medicenna Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Medicenna Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Medicenna Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Medicenna Therapeutics share be worth in 2023 - 2027?

When should I take profit in Medicenna Therapeutics stock? When should I record a loss on Medicenna Therapeutics stock? What are analysts' forecasts for Medicenna Therapeutics stock? What is the future of Medicenna Therapeutics stock? We forecast Medicenna Therapeutics stock performance using neural networks based on historical data on Medicenna Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Medicenna Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Medicenna Therapeutics shares. This happens once a day.

Historical and forecast chart of Medicenna Therapeutics stock

The chart below shows the historical price of Medicenna Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Medicenna Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.

Medicenna Therapeutics daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Sep 14	0.32	0.31	0.32	3.45
Sep 15	0.32	0.31	0.33	4.44
Sep 16	0.33	0.32	0.33	3.94
Sep 17	0.33	0.32	0.34	4.61
Sep 18	0.33	0.32	0.33	4.16
Sep 19	0.33	0.33	0.34	5.53
Sep 20	0.33	0.32	0.34	4.86
Sep 21	0.32	0.31	0.33	5.44
Sep 22	0.33	0.32	0.33	5.17
Sep 23	0.32	0.31	0.32	4.09
Sep 24	0.33	0.32	0.33	4.62
Sep 25	0.32	0.32	0.33	2.44
Sep 26	0.33	0.33	0.34	4.55
Sep 27	0.35	0.34	0.35	4.14
Sep 28	0.35	0.35	0.35	2.40
Sep 29	0.35	0.34	0.36	2.97
Sep 30	0.34	0.34	0.35	3.43
Oct 01	0.35	0.34	0.35	3.93
Oct 02	0.33	0.33	0.34	2.39
Oct 03	0.33	0.33	0.34	4.10
Oct 04	0.33	0.32	0.33	5.36
Oct 05	0.32	0.31	0.32	3.59
Oct 06	0.33	0.32	0.33	3.96
Oct 07	0.33	0.32	0.33	3.18
Oct 08	0.34	0.33	0.35	4.13
Oct 09	0.35	0.35	0.36	3.56
Oct 10	0.36	0.35	0.36	3.33
Oct 11	0.34	0.34	0.35	5.19
Oct 12	0.34	0.33	0.34	4.35
Oct 13	0.34	0.33	0.34	3.69

Medicenna Therapeutics Daily Price Targets

Medicenna Therapeutics Stock Forecast 09-14-2023.

Forecast target price for 09-14-2023: $0.32.
Negative dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 3.332%.
Pessimistic target level: 0.31
Optimistic target level: 0.32

Medicenna Therapeutics Stock Forecast 09-15-2023.

Forecast target price for 09-15-2023: $0.32.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 4.247%.
Pessimistic target level: 0.31
Optimistic target level: 0.33

Medicenna Therapeutics Stock Forecast 09-16-2023.

Forecast target price for 09-16-2023: $0.33.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 3.795%.
Pessimistic target level: 0.32
Optimistic target level: 0.33

Medicenna Therapeutics Stock Forecast 09-17-2023.

Forecast target price for 09-17-2023: $0.33.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 4.410%.
Pessimistic target level: 0.32
Optimistic target level: 0.34

Medicenna Therapeutics Stock Forecast 09-18-2023.

Forecast target price for 09-18-2023: $0.33.
Negative dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 3.996%.
Pessimistic target level: 0.32
Optimistic target level: 0.33

Medicenna Therapeutics Stock Forecast 09-19-2023.

Forecast target price for 09-19-2023: $0.33.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 5.243%.
Pessimistic target level: 0.33
Optimistic target level: 0.34

MDNA (MDNA) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Dec.	0.35	0.32	0.39	18.30

Full forecast for 2023

Medicenna Therapeutics forecast for this year

Medicenna Therapeutics Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $0.350982. Pessimistic: $0.32. Optimistic: $0.39

Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	0.42	0.38	0.43	11.71
Feb	0.40	0.38	0.44	12.34
Mar	0.34	0.31	0.38	17.90
Apr	0.32	0.29	0.36	17.89
May	0.35	0.33	0.39	17.08
Jun	0.39	0.35	0.44	21.37
Jul	0.37	0.33	0.42	21.15
Aug	0.37	0.33	0.42	19.72
Sep	0.44	0.38	0.46	16.66
Oct	0.47	0.43	0.53	19.52
Nov	0.39	0.35	0.44	21.26
Dec	0.43	0.40	0.48	17.67

Full forecast for 2024

Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.48	0.44	0.52	15.65
Feb	0.45	0.39	0.48	18.56
Mar	0.48	0.43	0.54	20.73
Apr	0.46	0.42	0.53	20.09
May	0.44	0.39	0.49	20.26
Jun	0.41	0.37	0.45	18.53
Jul	0.42	0.39	0.49	18.76
Aug	0.44	0.37	0.48	22.32
Sep	0.43	0.37	0.44	16.02
Oct	0.46	0.44	0.48	8.22
Nov	0.43	0.41	0.46	11.36
Dec	0.43	0.37	0.47	21.64

Full forecast for 2025

Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.46	0.43	0.50	13.10
Feb	0.50	0.43	0.54	19.88
Mar	0.45	0.39	0.48	19.56
Apr	0.44	0.42	0.49	12.97
May	0.45	0.42	0.47	11.86
Jun	0.37	0.32	0.43	25.36
Jul	0.35	0.33	0.38	13.68
Aug	0.40	0.36	0.46	22.67
Sep	0.40	0.38	0.44	13.78
Oct	0.36	0.35	0.38	9.22
Nov	0.38	0.35	0.43	18.95
Dec	0.41	0.35	0.45	23.25

Full forecast for 2026

Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.48	0.46	0.55	17.43
Feb	0.53	0.48	0.55	12.58
Mar	0.50	0.44	0.54	18.22
Apr	0.46	0.42	0.52	19.96
May	0.49	0.47	0.55	15.48
Jun	0.46	0.43	0.53	18.93
Jul	0.51	0.45	0.59	22.84
Aug	0.47	0.42	0.51	17.69
Sep	0.50	0.43	0.55	22.19
Oct	0.48	0.43	0.54	19.29
Nov	0.52	0.48	0.59	18.37
Dec	0.62	0.59	0.66	11.12

Full forecast for 2027

Medicenna Therapeutics information and performance

Medicenna Therapeutics Address

2 BLOOR ST W., 7TH FLOOR, TORONTO, ON, CA

Market Capitalization: 11 161 000 $

Market capitalization of the Medicenna Therapeutics Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MDNA shares in the company outstanding by the market price of one share.

EBITDA: -16 436 500 $

EBITDA of Medicenna Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.09

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 208.33

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.012

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 69638000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Context Therapeutics Inc. (CNTX)

IMV Inc. (IMV)

McKesson Corp. (MCK)

Bristol-Myers Squibb Company (BMY)

Zymeworks Inc. (ZYME)

Humana Inc. (HUM)

Fate Therapeutics, Inc. (FATE)

Dicerna Pharmaceuticals, Inc. (DRNA)

Cumberland Pharmaceuticals Inc. (CPIX)

Koninklijke Philips N.V. (PHG)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/MDNA.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/MDNA.svg"> Medicenna Therapeutics (MDNA) Stock Forecast for 2023 – 2026. Sell or Buy?